VTRS Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$19.70median target· current $18.66 (+5.6%)12 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
31 articles · sorted by datePage 1 of 2 · 31 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 6.38
EPS (TTM)$-0.36-70.6% YoY
Profit margin-2.8%HEALTHCARE
Market cap$21.43BLarge cap
Valuation
- Forward P/E
- 6.38
- PEG ratio
- 1.05
- P/B
- 1.38
- P/S (TTM)
- 1.45
- EV/EBITDA
- 11.86
Profitability & growth
- ROE (TTM)
- -2.8%
- Operating margin
- 12.6%
- Revenue growth YoY
- 4.9%
- Dividend yield
- 2.6%
- Beta
- 0.86
Last earnings
Aug 6, 2026 · Estimate $0.62 · Reported $0.69
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Viatris Inc
Company profileViatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
Classification
- Sector
- Healthcare
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- ROBERT J. COURY GLOBAL CENTER, CANONSBURG, PA
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$21.43B
Shares outstanding$1.15B
52W high$18.67
52W low$9.58
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent